ATRA

NASDAQStock

Atara Biotherapeutics, Inc.

$6.29-0.61 (-8.88%)

52-Week Range

$4.18

$18.09

Key Stats

Market Cap

—

P/E Ratio

1.91

Dividend Yield

—

Beta

-0.40

Volume

160.0K

Avg Volume

715.8K

Performance

+55.06%

-61.56%

-40.05%

YTD

-61.17%

-3.77%

-91.07%

-98.33%

Price Chart

ETF Exposure

ATRA is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.30%	108,596	$886K	$12.7M	0.79%
IWC	iShares Micro-Cap ETF	0.01%	10,514	$66K	$1.27B	0.60%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	880	$6K	$40.55B	0.17%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	7	$54	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	278	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$9	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	158,646	$825K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	834	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	71	$506	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	56,372	$293K	$84.10B	0.05%

About ATRA ETF Exposure

Atara Biotherapeutics, Inc. (ATRA) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.29. Investors can gain exposure to ATRA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ATRA, sorted by portfolio weight.